Search

everythinglearnresearchcommunity

for

Search:↓

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Testosterone improves mood and thinking skills; finasteride has no effect.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Some medications can help increase sexual desire and function in women.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The FDA did not approve a testosterone drug because of safety concerns.

Estrogen alone can lower testosterone in some transfeminine people.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The study concluded that the most common skin problems in women with PCOS are excess hair, acne, oily skin, hair loss, dark skin patches, and skin tags.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Ethosomes are a promising way to deliver drugs through the skin.

Applying EGCG on the skin can prevent hair loss caused by testosterone in mice.

The FDA rejected a testosterone drug again due to safety concerns.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.